Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05820893 · ClinicalTrials.gov registry record · Phase 2
Resistant Potato Starch to Alleviate GWI
A Phase 2 study of Gulf War Illness, sponsored by VA Office of Research and Development.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 52
- Enrollment target
- 1
- Study location
NCT05820893 is a Phase 2 study of Gulf War Illness that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 52 participants, below the 126-participant average among 14 other Gulf War Illness trials with a reported enrollment target (59% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05820893, a Phase 2 study of Gulf War Illness, is actively recruiting participants, sponsored by VA Office of Research and Development.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 52 participants
- Enrollment target
- 1
- Study location
Study Summary
Gulf War Illness (GWI) affects an estimated 25-32% of the over 700,000 coalition troops deployed to the Persian Gulf as part of the First Gulf War. GWI causes a range of pain, fatigue, gastrointestinal, skin, neurologic, and respiratory symptoms. New treatments to reduce GWI-associated morbidity are critically needed. Research suggests a role for the gastrointestinal microbiome in mediating health, including through impacting metabolism and immunity. The disruption of this microbiome plays a role in multiple diseases, and preliminary data suggest that Veterans with GWI have altered gut microbiota. The investigators will evaluate the effectiveness of a dietary fiber prebiotic supplement intervention on improving the quality of life of Veterans with GWI.
Conditions Studied
Interventions
- DRUG Resistant Potato Starch
Study Locations (1)
Wisconsin
- William S. Middleton Memorial Veterans Hospital, Madison, WI - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2025-02-03 |
| Est. Completion | 2028-06-30 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05820893
The ClinicalTrials.gov registry entry for NCT05820893 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 126-participant average among 14 other Gulf War Illness trials with a reported enrollment target (59% lower). The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Gulf War Illness appearing as the primary indexed condition, and to 1 intervention - of which Resistant Potato Starch is the first listed.
NCT05820893 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.
Frequently Asked Questions
What is clinical trial NCT05820893 about?
NCT05820893 is a clinical study titled "Resistant Potato Starch to Alleviate GWI". Gulf War Illness (GWI) affects an estimated 25-32% of the over 700,000 coalition troops deployed to the Persian Gulf as part of the First Gulf War. GWI causes a range of pain, fatigue, gastrointestinal, skin, neurologic, and respiratory symptoms. New treatments to reduce GWI-associated morbidity are...
What is the current status of trial NCT05820893?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 52 participants. The study started on 2025-02-03. Estimated completion is 2028-06-30.
What conditions does trial NCT05820893 study?
This clinical trial studies the following conditions: Gulf War Illness.
What interventions are being tested in trial NCT05820893?
The interventions under investigation include: Resistant Potato Starch (DRUG).
Who is sponsoring clinical trial NCT05820893?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05820893 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gulf War Illness
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ca-Mg Butyrate in GWI
RECRUITING · Phase 2
-
Study of Bacopa in Gulf War Illness Patients
RECRUITING · Phase 2
-
Confirmation of Diet as a Treatment for Gulf War Illness
RECRUITING · Phase 3
-
NIH Investigative Deep Phenotyping Study of Gulf War Veteran Health (Project NIH IN-DEPTH)
RECRUITING
-
Validating Gulf War Illness Blood Biomarkers
RECRUITING
-
Nicotinamide Riboside Clinical Trial for GWI
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.